RxDoctor Payments Data

Alvin Cohn, MD

Plastic Surgery · Vestavia, ALNPI 1568471548

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $12,349 of the $14,891 with a category attached, or 82.9%. 25 manufacturers reported payments, led by AbbVie at 48.7% of the total. Reporting peaked in 2019 at $5,680 and has fallen 53.3% since, to $2,655 in 2025.

$14,891in general payments, 2019–2025

Across 180 payments — averaging $82.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$7K
  • Integra Lifesciences Corporation$3K
  • Sientra, Inc.$2K
  • Merz North America, Inc.$497
  • Mentor Worldwide LLC$392
  • Elutia, Inc.$340
  • plus $2K from 19 others

What the payments were for

  • Travel & lodging$1,51510%
  • Food & beverage$12,34983%
  • Gifts$1,0277%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,891 in reported general payments places this provider in the 85th percentile of 35 plastic surgery providers in Alabama.

See all plastic surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$6,707
Medicare patients
14
Services billed
27

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron35$316
Cephalexin36$205
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen28$162
Cyclobenzaprine Hcl27$151
Zolpidem Tartrate18$33

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Vestavia

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →